Deal reflects Liberty Mutual\'s conviction to its focused Asia Pacific strategy BOSTON,March 3,2025-- Liberty Mutual Insurance has agreed to sell its operations in Thailand and Vietnam to Chubb Limit
READ MORESTOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]
BARCELONA,Spain,March 5,2025-- On March 3,as the global communications and technology community converged in Barcelona,forMWC Barcelona 2025,Yangtze Optical Fibre and Cable Joint Stock Limited Company
Info-Tech Research Group\'s premier IT event arrives in Australia for the first time,offering actionable insights to IT leaders and professionals in the APAC region on the future of technology. The i
Australia\'s largest celebration for Small Business Excellence SYDNEY,Nov. 21,2024--Entries have officially opened for the 2025 Australian Small Business Champion Awards - the nation\'s premier award
HONG KONG,Nov. 21,2024-- Asian Venture Capital Journal (AVCJ),part of Mergermarket and the leading provider of private equity and venture capital intelligence in Asia,this week hosted its 37th Annual
HONG KONG,Nov. 21,2024-- Kerry Logistics Network Limited (\'KLN\'; Stock Code 0636.HK)is pleased to announce the appointment of Wong Siew Loong as its Chief Commercial Officer for the Group and Managi
Tuesday,December 31,2024 – Monday,January 13,2025 (National holiday) TOKYO,Nov. 21,2024-- BELLUSTAR TOKYO,A Pan Pacific Hotel and HOTEL GROOVE SHINJUKU,A PARKROYAL Hotel (Shinjuku-ku,Tokyo;GeneralM
BEIJING,Nov. 19,2024-- China\'s continuous improvement of air quality and reduction of greenhouse gas emissions has benefited not only the country itself,but also the rest of Asia and the world,foreig
BEIJING,Nov. 19,2024-- In a fully equipped laboratory in Beijing,a dragon-head architectural component from the Tang Dynasty (618-907) discovered at theGuzhou ruins in Xiong\'an New Area,North China\'
Prioritizing research integrity with enhanced filters to address publication and citation manipulation
TAIPEI,Nov. 19,2024-- TAHO Pharmaceuticals Ltd. announced the dosing of the first subjects in its U.S. Phase III clinical trial for its lead product,TAH3311,an innovative antithrombotic oral dissolvin
New global survey by Heidrick & Struggles,BCG,and INSEAD,reveals growing confidence in sustainability governance,but boards and CEOs still lack confidence in each other\'s leadership
© OfficialAffairs
